We are one of eleven National Institute for Health Research (NIHR) MedTech and In vitro diagnostics Co-operatives (MICs) awarded funding by the NIHR, acting as a centre of expertise focusing on clinical areas of high burden of disease and unmet need for NHS patients across the UK.

Our focus is on cardiovascular disease; more than 7 million people in the UK are living with cardiovascular disease, which remains the UK’s biggest killer and the NHS spends a significant proportion of its budget on treatment and prevention of cardiovascular disease.

From 1st of April 2024, the cardiovascular MedTech Co-operative will become one of the National Institute for Health and Care Research (NIHR) HealthTech Research Centres (HRC) with designated funding focussing on Cardiovascular and Respiratory Medicine (CRM). The HRC is one of 14 new HealthTech Research Centres across England which received £42 million in total from the NIHR to develop innovative technology solutions to improve healthcare.

The NIHR HRC in Cardiovascular and Respiratory Medicine will collaborate with businesses to support the development of new medical devices, diagnostics, and digital technology aimed at helping patients better monitor their health, assisting clinicians with early diagnosis of illness, and improving cardiovascular and respiratory disease management.

What we do

With a focus on devices, we are more appropriately referred to as a ‘MedTech Co-operative’. We work in partnership with patients and patient groups, front-line staff, leading expert researchers, and the technology and device industry. Our aim is to develop healthcare solutions which will improve clinical care and outcomes for patients suffering from a wide range of cardiovascular conditions, with economic benefit to the National Health Service (NHS).Learn more about us.